rMark Bio, Inc.
- Headquarters
- Chicago, IL
- Founded
- 2015
- Latest Form D
- $1M, Oct 2019
- Total capital
- $1.1M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $1.1M
- 2 Form D · last Oct 2019
- 84 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- first 2021
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$1M
- Private capital raisedForm D · SEC · 1st filing$100K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
Researcher links verified by same-company patents and grants- Jason SmithResearcherExecutive Officer, DirectorLinked by 1 patent
- John ClymanDirectorNamed in SEC Form D filings
- Lev BeckerExecutive Officer, DirectorNamed in SEC Form D filings
- Mark AchierDirectorNamed in SEC Form D filings
- Mark AchlerDirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 1- GrantedSystems and Methods for Correlating Experimental Biological DatasetsUSPTOUS 10,984,487
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .